Skip to main content
Premium Trial:

Request an Annual Quote

Mark Wingerd, David Goodlett, Eugene Davidov, Paul Fletcher

Premium

Mark Wingerd has become director of the proteomics facility at the Institute of Systems Biology, the ISB said last week. He succeeds David Goodlett, who left for a faculty position at the University of Washington. Wingerd joins the institute from Pacific Northwest National Laboratory, where he helped establish a proteomics facility.


Eugene Davidov has been appointed as director of the Yale Center for Genomics and Proteomics, and Paul Fletcher as director of the center’s chemical genomics and screening facility. Before coming to Yale, Davidov was a principal investigator at Beyond Genomics. Prior to that, he worked at Millennium Pharmaceuticals and Anadys Pharmaceuticals. Davidov holds a PhD in biochemistry from Clark University. Fletcher joins Yale from Edison, NJ-based DGI BioTechnologies. He holds a PhD in reproductive physiology and biochemistry from the University of Wyoming.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.